These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25930988)

  • 1. Proteomic analysis of host brain components that bind to infectious particles in Creutzfeldt-Jakob disease.
    Kipkorir T; Colangelo CM; Manuelidis L
    Proteomics; 2015 Sep; 15(17):2983-98. PubMed ID: 25930988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly infectious CJD particles lack prion protein but contain many viral-linked peptides by LC-MS/MS.
    Kipkorir T; Tittman S; Botsios S; Manuelidis L
    J Cell Biochem; 2014 Nov; 115(11):2012-21. PubMed ID: 24933657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Creutzfeldt-Jakob disease agents reproduce prion protein-independent identities in cell cultures.
    Arjona A; Simarro L; Islinger F; Nishida N; Manuelidis L
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8768-73. PubMed ID: 15161970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CJD and Scrapie Require Agent-Associated Nucleic Acids for Infection.
    Botsios S; Manuelidis L
    J Cell Biochem; 2016 Aug; 117(8):1947-58. PubMed ID: 26773845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid chemical decontamination of infectious CJD and scrapie particles parallels treatments known to disrupt microbes and biofilms.
    Botsios S; Tittman S; Manuelidis L
    Virulence; 2015; 6(8):787-801. PubMed ID: 26556670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies.
    Manuelidis L
    J Cell Biochem; 2007 Mar; 100(4):897-915. PubMed ID: 17044041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication and spread of CJD, kuru and scrapie agents in vivo and in cell culture.
    Miyazawa K; Emmerling K; Manuelidis L
    Virulence; 2011; 2(3):188-99. PubMed ID: 21527829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25-nm virus-like particles.
    Manuelidis L; Yu ZX; Barquero N; Mullins B
    Proc Natl Acad Sci U S A; 2007 Feb; 104(6):1965-70. PubMed ID: 17267596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease.
    Manuelidis L; Sklaviadis T; Akowitz A; Fritch W
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5124-8. PubMed ID: 7761460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dementias, neurodegeneration, and viral mechanisms of disease from the perspective of human transmissible encephalopathies.
    Manuelidis L
    Ann N Y Acad Sci; 1994 Jun; 724():259-81. PubMed ID: 8030947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New molecular markers of early and progressive CJD brain infection.
    Lu ZY; Baker CA; Manuelidis L
    J Cell Biochem; 2004 Nov; 93(4):644-52. PubMed ID: 15660413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies.
    Kitamoto T; Tateishi J; Tashima T; Takeshita I; Barry RA; DeArmond SJ; Prusiner SB
    Ann Neurol; 1986 Aug; 20(2):204-8. PubMed ID: 3092727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protected endogenous retroviral sequences copurify with infectivity in experimental Creutzfeldt-Jakob disease.
    Akowitz A; Manuelidis EE; Manuelidis L
    Arch Virol; 1993; 130(3-4):301-16. PubMed ID: 8517790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
    Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
    Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous production of prions after infectious particles are eliminated: implications for Alzheimer's disease.
    Miyazawa K; Kipkorir T; Tittman S; Manuelidis L
    PLoS One; 2012; 7(4):e35471. PubMed ID: 22509412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoblotting of Creutzfeldt-Jakob disease prion proteins: host species-specific epitopes.
    Bockman JM; Prusiner SB; Tateishi J; Kingsbury DT
    Ann Neurol; 1987 Jun; 21(6):589-95. PubMed ID: 3300520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological analysis of host and agent effects on Creutzfeldt-Jakob disease and scrapie prion proteins.
    Bockman JM; Kingsbury DT
    J Virol; 1988 Sep; 62(9):3120-7. PubMed ID: 2900341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High CJD infectivity remains after prion protein is destroyed.
    Miyazawa K; Emmerling K; Manuelidis L
    J Cell Biochem; 2011 Dec; 112(12):3630-7. PubMed ID: 21793041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectivity and host responses in Creutzfeldt-Jakob disease.
    Manuelidis L; Fritch W
    Virology; 1996 Feb; 216(1):46-59. PubMed ID: 8615006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal prion protein, infectivity and neurofilament light-chain in blood of macaques with experimental variant Creutzfeldt-Jakob disease.
    Yakovleva O; Bett C; Pilant T; Asher DM; Gregori L
    J Gen Virol; 2022 Jul; 103(7):. PubMed ID: 35816369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.